2-Bromo-1,4-Naphthalenedione Promotes CD8+ T Cell Expansion and Limits Th1/Th17 to Mitigate Experimental Autoimmune Encephalomyelitis

0
49
Scientists explored the therapeutic potential of 2-bromo-1,4-naphthalenedione, a derivative of naphthalenedione, in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, and to elucidate its underlying mechanisms.
[Journal of Neuroinflammation]
Full Article